Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Mechanism of Angiogenesis01:10

Mechanism of Angiogenesis

6.9K
Blood vessel formation starts early during embryonic development, around day 7. In the extraembryonic yolk sac, mesodermal precursor cells called hemangioblast proliferate and differentiate into angioblast. Angioblasts express vascular endothelial growth factor receptor 2 or VEGFR2, which binds VEGF-A, a proangiogenic factor, guiding blood vessel formation. VEGF signaling promotes angioblasts to form a blood island in the developing embryo. Angioblasts further differentiate, giving rise to...
6.9K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

3.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Product of arachidonic acid oxidation inhibits neutrophil migration by forming the inflammatory substrate for integrin αMβ2.

Journal of immunology (Baltimore, Md. : 1950)·2026
Same author

Sex-specific angiogenic responses in endothelial cells-role of the pluripotency factor OCT4.

Angiogenesis·2025
Same author

Structural Insights into Recognition and Translocation of Oxidized Phospholipid by CD36 Using Mass Spectrometry, Molecular Docking, Dynamics, and Metadynamics Simulations.

Journal of the American Chemical Society·2025
Same author

Macrophage-Kruppel-Like Transcription Factor 6 Signaling Promotes Experimental Atherogenesis.

The American journal of pathology·2025
Same author

Mechanisms and consequences of myeloid adhesome dysfunction in atherogenesis.

Cardiovascular research·2024
Same author

TLR2 regulates hair follicle cycle and regeneration via BMP signaling.

eLife·2024

Related Experiment Video

Updated: Feb 7, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K

Angiogenesis in melanoma.

Ganapati H Mahabeleshwar1, Tatiana V Byzova

  • 1Department of Molecular Cardiology, J.J. Jacobs Center for Thrombosis and Vascular Biology, The Cleveland Clinic Foundation, Cleveland, OH 44195, USA.

Seminars in Oncology
|December 18, 2007
PubMed
Summary
This summary is machine-generated.

Angiogenesis, the formation of new blood vessels, is vital for melanoma growth and spread. Targeting key molecular pathways involved in this process offers promising therapeutic strategies for melanoma treatment.

More Related Videos

In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

8.5K
Rat Mesentery Angiogenesis Assay
18:30

Rat Mesentery Angiogenesis Assay

Published on: June 18, 2011

14.2K

Related Experiment Videos

Last Updated: Feb 7, 2026

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis
07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

2.9K
In Vitro Model of Coronary Angiogenesis
08:03

In Vitro Model of Coronary Angiogenesis

Published on: March 10, 2020

8.5K
Rat Mesentery Angiogenesis Assay
18:30

Rat Mesentery Angiogenesis Assay

Published on: June 18, 2011

14.2K

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Angiogenesis is essential for the progression and metastasis of solid tumors, particularly melanomas.
  • Melanoma cells secrete growth factors that stimulate blood vessel formation, crucial for tumor survival and spread.

Purpose of the Study:

  • To review the mechanisms of angiogenesis in melanoma.
  • To summarize current anti-angiogenic therapeutic strategies and their molecular targets in melanoma.

Main Methods:

  • Focused on key growth factors secreted by melanoma cells and their receptors on endothelial and melanoma cells.
  • Examined the synergistic roles of extracellular matrix receptors, integrins, and matrix metalloproteinases (MMPs) in angiogenesis.
  • Reviewed the impact of blocking these molecular systems on melanoma vascularization.

Main Results:

  • Growth factors, integrins, and MMPs are activated during key stages of melanoma angiogenesis, including endothelial migration and proliferation.
  • Blocking these molecules and their downstream pathways inhibits melanoma vascularization.
  • Numerous compounds targeting these angiogenic pathways are in late-stage clinical trials.

Conclusions:

  • The molecular systems regulating melanoma angiogenesis are critical for tumor progression.
  • These molecules represent promising therapeutic targets for anti-angiogenic interventions in melanoma.
  • Emerging anti-angiogenic therapies show potential for clinical application in melanoma treatment.